Methylphenidate treatment in the spontaneously hypertensive rat: Influence on methylphenidate self-administration and reinstatement in comparison with Wistar rats

Psychopharmacology

Volumn 221, Issue 2, 2012, Pages 217-226

  Dela Peña, Ike ^a   Yoon, Seo Young ^a   Lee, Jong Chan ^b   Dela Peña, June Bryan ^a   Sohn, Aee Ree ^a   Ryu, Jong Hoon ^c   Shin, Chan Young ^d   Cheong, Jae Hoon ^a  

^a Sahmyook University   (South Korea)

^b Chung Ang University   (South Korea)

^c Kyung Hee University   (South Korea)

^d Konkuk University   (South Korea)

Author keywords

Abuse liability; Chronic treatment; Fixed ratio; Methylphenidate; Progressive ratio; Reinstatement; Self administration; SHR; Wistar rats

Indexed keywords

METHYLPHENIDATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFECT; DRUG EXPOSURE; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETREATMENT; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; TREATMENT DURATION; TREATMENT RESPONSE; WISTAR RAT;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; EXTINCTION, PSYCHOLOGICAL; MALE; METHYLPHENIDATE; RATS; RATS, INBRED SHR; RATS, WISTAR; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; SPECIES SPECIFICITY;

EID: 84862661663     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2564-1     Document Type: Article

References (45)

1. Augustyniak PN, Kourrich S, Rezazadeh JS, Arvanitogiannis A (2006) Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder. Behav Brain Res 167:379-382
2. Botly LC, Burton CL, Rizos Z, Fletcher PJ (2008) Characterization of methylphenidate self-administration and reinstatement in the rat. Psychopharmacology 199:55-66
3. Cailhol S, Mormede P (1999) Strain and sex differences in the locomotor response and behavioral sensitization to cocaine in hyperactive rats. Brain Res 842:200-205
4. Dafny N, Yang PB (2006) The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects. Brain Res Bull 68:393-405
5. dela Peña IC, Ahn HS, Choi JY, Shin CY, Ryu JH, Cheong JH (2010) Reinforcing effects of methamphetamine in an animal model of attention-deficit/hyperactivity disorder - the spontaneously hypertensive rat. Behav Brain Funct 6:72
6. dela Peña IC, Ahn HS, Choi JY, Shin CY, Ryu JH, Cheong JH (2011a) Methylphenidate self-administration and conditioned place preference in an animal model of attention deficit hyperactivity disorder - the spontaneously hypertensive rat. Behav Pharmacol 22:31-39
7. dela Peña IC, Ahn HS, Shin CY, Cheong JH (2011b) Neuroadaptations involved in long-term exposure to ADHD pharmacotherapies: alterations that support dependence liability of these medications? Biomol Ther 19:9-20
8. Epstein DH, Preston KL, Stewart J, Shaham Y (2006) Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl) 189:1-16
9. Feltenstein MW, See RE (2008) The neurocircuitry of addiction: an overview. Br J Pharmacol 154(2):261-274
10. Gerasimov MR, Franceschi M, Volkow ND, Gifford A, Gatley SJ, Marsteller D, Molina PE, Dewey SL (2000) Comparison between intraperitoneal and oral methylphenidate administration: microdialysis and locomotor activity study. J Pharmacol Exp Ther 295:51-57
11. Gordon SM, Tulak F, Troncale J (2004) Prevalence and characteristics of adolescent patients with co-occurring ADHD and substance dependence. J Addict Dis 23(4):31-40
12. Heal DJ, Cheetham SC, Smith SL (2009) The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology 57:608-618
13. Horger BA, Shelton K, Schenk S (1990) Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol Biochem Behav 37:707-711
14. Kollins SH (2008) ADHD, Substance use disorders, and psychostimulant treatment: current literature and treatment guidelines. J Atten Disord 12:115-125
15. Kollins SH, MacDonald EK, Rush CR (2001) Assessing the abuse potential of methylphenidate in nonhuman and human subjects: review. Pharmacol Biochem Behav 68:611-627
16. Lorrain DS, Arnold GM, Vezina P (2000) Previous exposure to amphetamine increases incentive to obtain the drug: long-lasting effects revealed by the progressive ratio schedule. Behav Brain Res 107:9-19
17. Marco EM, Adriani W, Ruocco LA, Canese R, Sadile AG, Laviola G (2011) Neurobehavioral adaptations to methylphenidate: the issue of early adolescent exposure. Neurosci Biobehav Rev 35:1722-1739
18. Mendrek A, Blaha CD, Phillips AG (1998) Pre-exposure of rats to amphetamine sensitized self-administration of this drug under a progressive ratio schedule. Psychopharmacology 135:416-422
19. 2-receptor antagonists. J Pharmacol Exp Ther 298:539-550
20. Okamoto K, Aoki K (1963) Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27:282-293
21. Piazza PV, Deminiere JM, LeMOal M, Simon H (1990) Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res 514:22-66
22. Post RM, Weiss SR, Pert A (1988) Cocaine-induced behavioral sensitization and kindling: implications for the emergence of psychopathology and seizures. Ann NY Acad Sci 537:292-308
23. Richardson NR, Roberts DC (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66:1-11
24. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291
25. Russell VA (2005) The spontaneously hypertensive rat as an animal model of attention deficit hyperactivity disorder. In: Gozal D, Molfese D (eds) Attention deficit hyperactivity disorder: from genes to patient, 1st edn. Humana Press, New Jersey, p 81
26. Russell VA, de Villiers AS, Sagvolden T, Lamm MC, Taljaard JJ (1995) Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate putamen of an animal model of attention-deficit hyperactivity disorder - the spontaneously hypertensive rat. Brain Res 676:343-351
27. Russell VA, de Villiers AS, Sagvolden T, Lamm MC, Taljaard JJ (2000) Methylphenidate affects striatal dopamine differently in an animal model for attention deficit/hyperactivity disorder - the spontaneously hypertensive rat. Brain Res Bull 53:187-192
28. Russell VA, Sagvolden T, Johansen EB (2005) Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct 1:9
29. Sagvolden T (2000) Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24:31-39
30. Sagvolden T, Metzger MA, Schiørbeck HK, Rugland AL, Spinnangr I, Sagvolden G (1992) The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav Neural Biol 58:103-112
31. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M (2005) Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1239-1247
32. Schenk S, Partridge B (1999) Cocaine-seeking produced by experimenter-administered drug injections: dose-effect relationships in rats. Psychopharmacology (Berl) 147:285-290
33. Segal DS, Kuczenski R (1987) Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates. J Pharmacol Exp Ther 242:917-926
34. Smith GP, Schneider LH (1988) Relationships between mesolimbic dopamine function and eating behavior. Ann NY Acad Sci 537:254-261
35. 1 dopamine receptor dependent manner. Neuropsychopharmacology 27:970-979
36. Van der Kooij MA, Glennon JC (2007) Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. Neurosci Biobehav Rev 31:597-618
37. Vendruscolo LF, Izidio GS, Takahashi RN (2009) Drug reinforcement in a rat model of attention deficit/hyperactivity disorder - the spontaneously hypertensive rat (SHR). Curr Drug Abuse Rev 2:177-183
38. Volkow ND, Insel TR (2003) What are the long-term effects of methylphenidate treatment? Biol Psychiatry 54:1307-1309
39. Wilens TE, Kwon A, Tanguay S, Chase R, Moore H, Faraone SV, Biederman J (2005) Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. Am J Addict 14(4):319-327
40. Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S (2008) Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 47:21-31
41. Winger G, Woods JH (1985) Comparison of fixed-ration and progressive-ratio schedules of maintenance of stimulant drug-reinforced responding. Drug Alcohol Dep 15:123-130
42. Yang PB, Behrang A, Swann A, Nachum D (2003) Strain differences in the behavioral responses of male rats to chronically administered methylphenidate. Brain Res 971:139-152
43. Yang PB, Cuellar DO, Swann AC, Dafny N (2011) Age and genetic strain differences in response to chronic methylphenidate administration. Behav Brain Res 218:206-217
44. Yano M, Steiner H (2007) Methylphenidate and cocaine: the same effects on gene regulation. Trends Pharmacol Sci 28:588-596
45. Zhang XY, Kosten TA (2007) Previous exposure to cocaine enhances cocaine self-administration in an alpha 1-adrenergic receptor dependent manner. Neuropsychopharmacology 32: 638-645